Features
India’s pharmaceutical sector is not only a cornerstone of its national economy, but it’s also a pivotal player on a global stage. As of 2023, India ranked as the third-largest producer of drugs and pharmaceuticals by volume, with a 20% global share in the export of generic drugs. Currently valued at US$50 billion, the country has an ambitious goal for the sector: to grow its value to US$450...
11 June 2025 - 11 June 2025
We are looking forward to meet you during our next ISPE Belgium Affiliate afterwork networking event on 11 June 2025. Progress or Peril? Navigating the Future of Technology Keynote speaker Filip Van den Abeele 11 June 2025 - Diegem Scientific...
iSpeak Blog

The future of the pharmaceutical industry is being shaped by rapid advancements in digital technologies, automation, and data analytics. As we look ahead to 2025, the concept of Pharma 4.0™ is no longer just an aspirational vision—it is becoming a transformative reality that will redefine how medicines are developed, manufactured, and delivered to patients.

iSpeak Blog

Lindsey Daniel, Director of Product Operations Strategy and Business Lead at Takeda, is an exemplary champion for and beneficiary of ISPE. Daniel embodies leadership and collaboration in numerous ways: as a mentor, mentee, friend, colleague, mother, and more. With over 12 years of active involvement with ISPE, she has served on various committees, including ISPE’s International Women in...

iSpeak Blog

In the pharmaceutical industry, ensuring the safety, quality, and efficacy of products is paramount. With the increasing complexity of manufacturing processes, the growing reliance on computerized systems and advancements in technology, GAMP® guidance provides a framework for validating and maintaining the integrity of computerized systems, ensuring they are fit for their intended...

iSpeak Blog

The presentation by Ian Deveau, PhD, from the US Food and Drug Administration (US FDA) Office of Compounding Quality and Compliance at the 2024 ISPE Annual Meeting & Expo on 15 October 2024 provided an in-depth look at the US FDA’s perspective on drug compounding, its regulatory framework, and the significant events that have shaped current practices. Here is a summary of the key points...

2 April 2025 - 2 April 2025
ISPE DVC Private Charter Bus to INTERPHEX Need a ride to INTERPHEX 2025 this year? Ditch the stress of NYC traffic and parking worries and come ride with the ISPE DVC crew to this year’s event. Our comfortable private motor coach charter includes...
1 May 2025 - 1 May 2025
Unlocking the Power of Prediction: See Your Systems in a New Light This exclusive event will explore how Digital Twins are revolutionizing our industry. Join Denny Woolley, Senior Process Engineer at Genesis AEC, and Pam Docherty, Enterprise Account...
iSpeak Blog

Every dose of medicine represents a promise of quality—a commitment to safety, efficacy, and availability for the patients who depend on it. At the 2024 ISPE Annual Meeting & Expo, Jennifer Maguire, PhD, Director of the US Food and Drug Administration’s (US FDA) Office of Quality Surveillance (OQS), outlined how the agency is transforming its approach to pharmaceutical quality surveillance...

Subscribe to